These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 16377693

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics/pharmacodynamics of antofloxacin hydrochloride in a neutropenic murine thigh model of Staphylococcus aureus infection.
    Xiao XM, Xiao YH.
    Acta Pharmacol Sin; 2008 Oct; 29(10):1253-60. PubMed ID: 18817632
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In Vivo Pharmacodynamic Target Assessment of Delafloxacin against Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae in a Murine Lung Infection Model.
    Lepak AJ, Andes DR.
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4764-9. PubMed ID: 27216072
    [Abstract] [Full Text] [Related]

  • 12. In vitro pharmacokinetic/pharmacodynamic activity of NXL103 versus clindamycin and linezolid against clinical Staphylococcus aureus and Streptococcus pyogenes isolates.
    Vidaillac C, Parra-Ruiz J, Winterfield P, Rybak MJ.
    Int J Antimicrob Agents; 2011 Oct; 38(4):301-6. PubMed ID: 21764263
    [Abstract] [Full Text] [Related]

  • 13. Activity of a new oral streptogramin, XRP2868, against gram-positive cocci harboring various mechanisms of resistance to streptogramins.
    Dupuis M, Leclercq R.
    Antimicrob Agents Chemother; 2006 Jan; 50(1):237-42. PubMed ID: 16377692
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. In vivo pharmacodynamic characterization of a novel plectasin antibiotic, NZ2114, in a murine infection model.
    Andes D, Craig W, Nielsen LA, Kristensen HH.
    Antimicrob Agents Chemother; 2009 Jul; 53(7):3003-9. PubMed ID: 19414576
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In Vivo Pharmacodynamic Characterization of a Novel Odilorhabdin Antibiotic, NOSO-502, against Escherichia coli and Klebsiella pneumoniae in a Murine Thigh Infection Model.
    Zhao M, Lepak AJ, Marchillo K, VanHecker J, Andes DR.
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987156
    [Abstract] [Full Text] [Related]

  • 18. Determination of the pharmacodynamic profile of daptomycin against Streptococcus pneumoniae isolates with varying susceptibility to penicillin in a murine thigh infection model.
    Dandekar PK, Tessier PR, Williams P, Zhang C, Nightingale CH, Nicolau DP.
    Chemotherapy; 2004 Apr; 50(1):11-6. PubMed ID: 15084799
    [Abstract] [Full Text] [Related]

  • 19. Effects of various media on the activity of NXL103 (formerly XRP 2868), a new oral streptogramin, against Haemophilus influenzae.
    Pankuch GA, Hoellman D, Bryskier A, Lowther J, Appelbaum PC.
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3914-6. PubMed ID: 17065630
    [Abstract] [Full Text] [Related]

  • 20. In vivo pharmacodynamic activity of daptomycin.
    Safdar N, Andes D, Craig WA.
    Antimicrob Agents Chemother; 2004 Jan; 48(1):63-8. PubMed ID: 14693519
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.